Valencia Nutrition Ltd
Incorporated in 2013, Valencia Nutrition Ltd is in the business of developing, manufacturing, sales & distribution of nutraceutical products[1]
- Market Cap ₹ 110 Cr.
- Current Price ₹ 64.0
- High / Low ₹ 97.1 / 35.8
- Stock P/E 37.4
- Book Value ₹ 22.0
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.91 times its book value
- Company has high debtors of 279 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Beverages Other Beverages
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | TTM | |
|---|---|---|
| 8.47 | 10.62 | |
| 7.70 | 7.67 | |
| Operating Profit | 0.77 | 2.95 |
| OPM % | 9.09% | 27.78% |
| 0.65 | 0.67 | |
| Interest | 0.13 | 0.15 |
| Depreciation | 0.21 | 0.52 |
| Profit before tax | 1.08 | 2.95 |
| Tax % | 0.00% | |
| 1.07 | 2.95 | |
| EPS in Rs | 0.63 | 1.74 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 34% |
| 3 Years: | 74% |
| 1 Year: | 41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Sep 2025 | |
|---|---|---|
| Equity Capital | 16.98 | 16.98 |
| Reserves | 19.60 | 20.35 |
| 1.49 | 17.79 | |
| 0.35 | 0.80 | |
| Total Liabilities | 38.42 | 55.92 |
| 6.19 | 5.97 | |
| CWIP | 0.00 | 11.85 |
| Investments | 2.93 | 0.92 |
| 29.30 | 37.18 | |
| Total Assets | 38.42 | 55.92 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| -15.73 | |
| -10.17 | |
| 33.57 | |
| Net Cash Flow | 7.67 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Debtor Days | 279.24 |
| Inventory Days | 216.24 |
| Days Payable | 10.57 |
| Cash Conversion Cycle | 484.91 |
| Working Capital Days | 734.31 |
| ROCE % |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8h - RTA certifies Reg.74(5) not applicable; all shares dematerialised; no rematerialisation requests for quarter ended Dec 31, 2025.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
15 Jan - Inaugurated Units I & II in Hyderabad; combined 510,000 bottles/day; roadmap to 27 integrated plants by 2030.
-
Submission Of Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
1 Dec 2025 - Promoter/Promoter group acquired shares on November 27, 2025; disclosure submitted under SEBI Reg 7(2).
-
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, November 25, 2025
25 Nov 2025 - Allotment of 250,000 equity shares at Rs54 each (Rs1.35 crore) on Nov 25, 2025 to two investors.
-
Intimation Regarding Receipt Of In-Principle Approval Of BSE Limited For Issue Of Equity Shares To Promotor And Non-Promotor Category On A Preferential Basis.
15 Nov 2025 - BSE in-principle approval (14 Nov 2025) for preferential issue of 250,000 shares at ≥Rs54.
Business Overview:[1][2]
VNL is a BSE Start Up Listed Corporate Company since January 2020. It is an applied biotechnology company focused on research, developing & marketing Ready to Drink nutraceuticals, Ready-to-Mix nutraceuticals (Ease Out Sachets) viz. AL Cans, Sachets, PET bottles, PET Cans, Tetra Pack, and Refreshment Mints etc. to prevent or manage lifestyle related diseases